We’d love to hear your feedback on this activity. It helps us to continually improve our products.
Complex 3D mappings indicated a need for an endocardial and epicardial approach to treat patients with a long standing persistent form of atrial fibrillation. In this touchCARDIO interview, we speak with Dr Nicolas Doll (Schuechtermann-Clinic, Bad Rothenfelde, Germany) to discuss the history of atrial fibrillation surgery and the unmet needs for these patients. Nicolas Doll […]
The AMALFI trial aims to assess the efficacy and cost effectiveness of an ECG patch to monitor for atrial fibrillation. In this touchCARDIO interview, we speak with Dr Rohan Wijesurendra (University of Oxford, Oxford, UK) to discuss the design of the trial, when results should be expected and the hopeful clinical implications. The abstract entitled […]
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, but is often troublesome to monitor for in patients who present infrequently or as clinically silent. In this touchCARDIO interview, we speak with Dr Rohan Wijesurendra (University of Oxford, Oxford, UK) to discuss the challenges in the diagnosis of AF. Dr Wijesurendra presented an abstract […]
The European Stroke Organisation Conference (ESOC) 2023 will take place 24-26 May 2023 in Munich, Germany. The conference will include sessions, plenary lectures, and symposia, covering a wide range of topics related to stroke, including acute management, rehabilitation, imaging, epidemiology, and public health. Prof. Peter Kelly (President, European Stroke Organisation, Dublin, Ireland) joins touchCARDIO to discuss […]
The Evolut low risk trial aimed to compare transcatheter versus surgical aortic valve replacement in patients who were at low risk for surgery. In this touchCARDIO interview, we speak with Dr John Forrest (Yale New Haven Hospital, Yale University, New Haven, CT, USA) to discuss the eligibility criteria, the key findings and the outlook for […]
The treatment paradigm for aortic stenosis has developed dramatically in the past decade. In this touchCARDIO interview, we speak with Dr John Forrest (Yale New Haven Hospital, Yale University, New Haven, CT, USA) to outline and discuss the developments. Dr Forrest presented an abstract entitled ‘Transcatheter Versus Surgical Aortic Valve Replacement In Aortic Stenosis Patients […]
Recommended therapy for patients with pulmonary arterial hypertension is generally a combination of an endothelin receptor antagonist and a phosphodiesterase type 5 inhibitor. In this touchCARDIO interview, we speak with Dr Kelly Chin (UT Southwestern Medical Centre, Dallas, TX, USA) to discuss the treatment paradigm. Dr Chin presented an abstract entitled ‘Efficacy And Safety Of […]
The aim of the A DUE study was to assess the combination of macitentan and tadalafil for patients with pulmonary arterial hypertension. In this touchCARDIO interview, we speak with Dr Kelly Chin (UT Southwestern Medical Centre, Dallas, TX, USA) to discuss the findings of the trial and the clinical impact. The abstract entitled ‘Efficacy And […]
Transcatheter edge-to-edge repair (TEER) is a minimally invasive procedure that can effectively treat functional mitral regurgitation in heart failure patients. Compared to traditional surgical approaches, TEER offers benefits such as reduced hospital stay, lower risk of bleeding and infection, and faster recovery time. Additionally, TEER has been found to improve symptoms and quality of life […]
Get the latest clinical insights from touchCARDIO